List of Tables
Table 1. Clinical Next Generation Sequencing (NGS) Market Trends
Table 2. Clinical Next Generation Sequencing (NGS) Market Drivers & Opportunity
Table 3. Clinical Next Generation Sequencing (NGS) Market Challenges
Table 4. Clinical Next Generation Sequencing (NGS) Market Restraints
Table 5. Global Clinical Next Generation Sequencing (NGS) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Clinical Next Generation Sequencing (NGS) Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Clinical Next Generation Sequencing (NGS) Product Type
Table 9. Key Companies Time to Begin Mass Production of Clinical Next Generation Sequencing (NGS)
Table 10. Global Clinical Next Generation Sequencing (NGS) Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Next Generation Sequencing (NGS) as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Clinical Next Generation Sequencing (NGS) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Clinical Next Generation Sequencing (NGS) Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Clinical Next Generation Sequencing (NGS) Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Clinical Next Generation Sequencing (NGS) Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Clinical Next Generation Sequencing (NGS) Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Clinical Next Generation Sequencing (NGS) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Clinical Next Generation Sequencing (NGS) Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Clinical Next Generation Sequencing (NGS) Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Clinical Next Generation Sequencing (NGS) Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Clinical Next Generation Sequencing (NGS) Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Clinical Next Generation Sequencing (NGS) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Clinical Next Generation Sequencing (NGS) Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Clinical Next Generation Sequencing (NGS) Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Clinical Next Generation Sequencing (NGS) Sales Value by Region (2019-2024) & (%)
Table 27. Global Clinical Next Generation Sequencing (NGS) Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Clinical Next Generation Sequencing (NGS) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Clinical Next Generation Sequencing (NGS) Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Clinical Next Generation Sequencing (NGS) Sales Value, (2025-2030) & (US$ Million)
Table 31. Agilent Technologies Basic Information List
Table 32. Agilent Technologies Description and Business Overview
Table 33. Agilent Technologies Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 34. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Agilent Technologies (2019-2024)
Table 35. Agilent Technologies Recent Developments
Table 36. Illumina Basic Information List
Table 37. Illumina Description and Business Overview
Table 38. Illumina Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 39. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Illumina (2019-2024)
Table 40. Illumina Recent Developments
Table 41. Thermo Fisher Scientific Basic Information List
Table 42. Thermo Fisher Scientific Description and Business Overview
Table 43. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 44. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Thermo Fisher Scientific (2019-2024)
Table 45. Thermo Fisher Scientific Recent Developments
Table 46. Eurofins Scientific Basic Information List
Table 47. Eurofins Scientific Description and Business Overview
Table 48. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 49. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Eurofins Scientific (2019-2024)
Table 50. Eurofins Scientific Recent Developments
Table 51. BGI Group Basic Information List
Table 52. BGI Group Description and Business Overview
Table 53. BGI Group Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 54. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of BGI Group (2019-2024)
Table 55. BGI Group Recent Developments
Table 56. Qiagen Basic Information List
Table 57. Qiagen Description and Business Overview
Table 58. Qiagen Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 59. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Qiagen (2019-2024)
Table 60. Qiagen Recent Developments
Table 61. Roche Diagnostics Basic Information List
Table 62. Roche Diagnostics Description and Business Overview
Table 63. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 64. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Roche Diagnostics (2019-2024)
Table 65. Roche Diagnostics Recent Developments
Table 66. Bio-Rad Basic Information List
Table 67. Bio-Rad Description and Business Overview
Table 68. Bio-Rad Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 69. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Bio-Rad (2019-2024)
Table 70. Bio-Rad Recent Developments
Table 71. Congenica Basic Information List
Table 72. Congenica Description and Business Overview
Table 73. Congenica Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 74. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Congenica (2019-2024)
Table 75. Congenica Recent Developments
Table 76. Theragen Etex Basic Information List
Table 77. Theragen Etex Description and Business Overview
Table 78. Theragen Etex Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 79. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Theragen Etex (2019-2024)
Table 80. Theragen Etex Recent Developments
Table 81. PerkinElmer Basic Information List
Table 82. PerkinElmer Description and Business Overview
Table 83. PerkinElmer Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 84. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of PerkinElmer (2019-2024)
Table 85. PerkinElmer Recent Developments
Table 86. Partek Basic Information List
Table 87. Partek Description and Business Overview
Table 88. Partek Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 89. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Partek (2019-2024)
Table 90. Partek Recent Developments
Table 91. Oxford Nanopore Technologies Basic Information List
Table 92. Oxford Nanopore Technologies Description and Business Overview
Table 93. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 94. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Oxford Nanopore Technologies (2019-2024)
Table 95. Oxford Nanopore Technologies Recent Developments
Table 96. Pacific Biosciences of California Basic Information List
Table 97. Pacific Biosciences of California Description and Business Overview
Table 98. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 99. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Pacific Biosciences of California (2019-2024)
Table 100. Pacific Biosciences of California Recent Developments
Table 101. Golden Helix Basic Information List
Table 102. Golden Helix Description and Business Overview
Table 103. Golden Helix Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 104. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of Golden Helix (2019-2024)
Table 105. Golden Helix Recent Developments
Table 106. BioDatomics Basic Information List
Table 107. BioDatomics Description and Business Overview
Table 108. BioDatomics Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 109. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of BioDatomics (2019-2024)
Table 110. BioDatomics Recent Developments
Table 111. PierianDx Basic Information List
Table 112. PierianDx Description and Business Overview
Table 113. PierianDx Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 114. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of PierianDx (2019-2024)
Table 115. PierianDx Recent Developments
Table 116. DNAStar Basic Information List
Table 117. DNAStar Description and Business Overview
Table 118. DNAStar Clinical Next Generation Sequencing (NGS) Products, Services and Solutions
Table 119. Revenue (US$ Million) in Clinical Next Generation Sequencing (NGS) Business of DNAStar (2019-2024)
Table 120. DNAStar Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Clinical Next Generation Sequencing (NGS) Downstream Customers
Table 124. Clinical Next Generation Sequencing (NGS) Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Clinical Next Generation Sequencing (NGS) Product Picture
Figure 2. Global Clinical Next Generation Sequencing (NGS) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Clinical Next Generation Sequencing (NGS) Sales Value (2019-2030) & (US$ Million)
Figure 4. Clinical Next Generation Sequencing (NGS) Report Years Considered
Figure 5. Global Clinical Next Generation Sequencing (NGS) Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Clinical Next Generation Sequencing (NGS) Revenue in 2023
Figure 7. Clinical Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Sequencing by Synthesis (SBS) Picture
Figure 9. Nanopore Sequencing Picture
Figure 10. Single-Molecule Real-Time (SMRT) Sequencing Picture
Figure 11. Others Picture
Figure 12. Global Clinical Next Generation Sequencing (NGS) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Clinical Next Generation Sequencing (NGS) Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Diagnostics
Figure 15. Product Picture of Drug Discovery & Designing
Figure 16. Product Picture of Medical Research
Figure 17. Product Picture of Others
Figure 18. Global Clinical Next Generation Sequencing (NGS) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Clinical Next Generation Sequencing (NGS) Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Clinical Next Generation Sequencing (NGS) Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Clinical Next Generation Sequencing (NGS) Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Clinical Next Generation Sequencing (NGS) Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Clinical Next Generation Sequencing (NGS) Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Clinical Next Generation Sequencing (NGS) Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Clinical Next Generation Sequencing (NGS) Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Clinical Next Generation Sequencing (NGS) Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Clinical Next Generation Sequencing (NGS) Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Clinical Next Generation Sequencing (NGS) Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Clinical Next Generation Sequencing (NGS) Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Clinical Next Generation Sequencing (NGS) Sales Value (%), (2019-2030)
Figure 31. United States Clinical Next Generation Sequencing (NGS) Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Clinical Next Generation Sequencing (NGS) Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Clinical Next Generation Sequencing (NGS) Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Clinical Next Generation Sequencing (NGS) Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Clinical Next Generation Sequencing (NGS) Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Clinical Next Generation Sequencing (NGS) Sales Value by Application (%), 2023 VS 2030
Figure 37. China Clinical Next Generation Sequencing (NGS) Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Clinical Next Generation Sequencing (NGS) Sales Value by Type (%), 2023 VS 2030
Figure 39. China Clinical Next Generation Sequencing (NGS) Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Clinical Next Generation Sequencing (NGS) Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Clinical Next Generation Sequencing (NGS) Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Clinical Next Generation Sequencing (NGS) Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Clinical Next Generation Sequencing (NGS) Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Clinical Next Generation Sequencing (NGS) Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Clinical Next Generation Sequencing (NGS) Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Clinical Next Generation Sequencing (NGS) Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Clinical Next Generation Sequencing (NGS) Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Clinical Next Generation Sequencing (NGS) Sales Value by Application (%), 2023 VS 2030
Figure 49. India Clinical Next Generation Sequencing (NGS) Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Clinical Next Generation Sequencing (NGS) Sales Value by Type (%), 2023 VS 2030
Figure 51. India Clinical Next Generation Sequencing (NGS) Sales Value by Application (%), 2023 VS 2030
Figure 52. Clinical Next Generation Sequencing (NGS) Industrial Chain
Figure 53. Clinical Next Generation Sequencing (NGS) Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
